← back to search

Zhong Zuo

University of Oklahoma Health Sciences Center · US
Area of research
Oncology · Complementary and alternative medicine
Research interest
Research interests include Pharmacology, Chemistry, Pharmacokinetics, In vivo, Piperine, and Bioavailability.
h-index
citations
1,168
works
15
NIH funding
primary concept
email

Recent publications

Schisandrol B protects against lithocholic acid-induced cholestatic liver injury in mice through mitochondrial biogenesis
Chinese Medicine 2026cited by 0position: middledoi
Significantly Increased Aqueous Solubility of Piperine via Nanoparticle Formulation Serves as the Most Critical Factor for Its Brain Uptake Enhancement.
PubMed 2025cited by 2position: lastdoi
Precision engineering of anti-atherosclerotic herbal nanomedicine: from machine learning-aided active components screening to optimized metal-phenolic network codelivery
Drug Delivery and Translational Research 2025cited by 1position: middledoi
Development of dissolution method for Chuanxinlian tablets based on in vitro-in vivo correlation model for multi-components
Journal of Drug Delivery Science and Technology 2024cited by 1position: middledoi
<i>Lactobacillus gallinarum</i>-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
Gut 2023cited by 249position: middledoi
Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice
Phytomedicine 2022cited by 26position: lastdoi
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
ACS Central Science 2021cited by 86position: middledoi
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
Journal of Controlled Release 2020cited by 165position: middledoi
Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities
Journal of Ethnopharmacology 2020cited by 30position: lastdoi
Identification of the in vivo relevant dissolution media for the three active components in EGb 761 tablet for better correlation with their pharmacokinetics in healthy subjects
European Journal of Pharmaceutical Sciences 2020cited by 10position: lastdoi
Current trends in drug metabolism and pharmacokinetics
Acta Pharmaceutica Sinica B 2019cited by 372position: middledoi
Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control
European Journal of Pharmaceutical Sciences 2019cited by 83position: lastdoi
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space
ACS Central Science 2018cited by 43position: middledoi
Bioavailability enhancement of glucosamine hydrochloride by chitosan
International Journal of Pharmaceutics 2013cited by 43position: lastdoi
The anti‐cancer agent <scp>SU4312 u</scp>nexpectedly protects against <scp>MPP<sup>+</sup></scp>‐induced neurotoxicity via selective and direct inhibition of neuronal <scp>NOS</scp>
British Journal of Pharmacology 2012cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jianxin Wang · Qingdao University of Technology3 papers (2020–2020)Cuiping Jiang · Guangzhou University of Chinese Medicine2 papers (2025–2025)Chunbo Zhang · Nanchang University2 papers (2019–2022) · 2 papers (2019–2020)Yuanfeng Lyu · China Pharmaceutical University2 papers (2019–2022)Sharon Shui Yee Leung · Chinese University of Hong Kong2 papers (2019–2025)Jiajia Zhao · Xi'an University of Science and Technology2 papers (2020–2020)Jiaxuan Xia · Fudan University1 papers (2020–2020)Anni Wang · University of Chicago1 papers (2020–2020)Yifan Han · Zhejiang Chinese Medical University1 papers (2012–2012)Xiaoyan Chen · Fudan University1 papers (2019–2019)Sai Li · Shanxi University1 papers (2012–2012)Xin Wang · Nanchang University1 papers (2019–2019)Jiahao Li · Anhui Jianzhu University1 papers (2025–2025)Qi Wang · Guangxi University1 papers (2020–2020)Qi Wang · The University of Texas MD Anderson Cancer Center1 papers (2024–2024)Huan Zhang · Tianjin University of Traditional Chinese Medicine1 papers (2012–2012)Xiang Zhang · Chinese University of Hong Kong1 papers (2023–2023)Kun Li · University of Wollongong1 papers (2020–2020)Kun Li · Guangzhou University of Chinese Medicine1 papers (2020–2020)